Home[English] » Faculty and Staff » Dental faculty » Nicolatou Ourania

Ourania Nicolatou-Galitis

Professor


Phone: (+30) 210-746-1185
Email: onikolat[at]dent.uoa[dot]gr

Mailing Address:
2 Thivon Str, 115 27, Goudi, Athens, Greece

Ελληνική Έκδοση English Version

Education / Qualifications

  • 1975: DDS, School of Dentistry, University of Athens, Greece
  • 1979: MSc, Certificate in Oral Pathology, Temple University, Philadelphia, USA
  • 1979: DrDent, School of Dentistry, University of Athens, Greece

Academic and professional positions held

  • 1980: Lecturer, Department of Stomatology, School of Dentistry, University of Athens, Greece
  • 2010 – present : Professor, Hospital Dentistry, School of Dentistry, University of Athens, Greece

Academic and professional responsibilities

  • Head of the Clinic of Hospital Dentistry, University of Athens, Greece
  • President of the Hellenic Association of Supportive Care of the Oral Cavity in Cancer
  • Member of the Board of the Hellenic Society of Medical Mycology, 2003-2005 & 2005-2008.
  • Co-Chair of the Bone Study Group
  • Member of the Leadership Group for Mucositis
  • President Elect of the International Society of Oral Oncology
  • Board Member of the Mediterranean Oncology Forum – MMOF
  • Editor-in-Chief of the Mediterranean Oncology Journal – MOJ
  • Active member of the Quality of Life Department, European Organization for the Research and Treatment of Cancer – EORTC

Research Grants and Contracts

  • 1999: General Secretariat for Research & Technology
  • 2014: International Registry for the Osteonecrosis of the Jaw

European Organization for the Research and Treatment of Cancer-EORTC-Quality of Life Department, ongoing:

  • Development of an Οral Ηealth Quality of Life Module (phase I to IV of the EORTC Μodule development).
  • Update of the EORTC QLQ-H&N35, Phase I/IV, Head and Neck Quality of   Life Questionnaire Module.
  • Patient Reported Outcomes in Chronic Myeloid Leukemia. Phase I-II. GIMEMA QoL – CML0310.
  • Development of a symptom based questionnaire: the development of a time-efficient procedure.   
  • Development of a module to supplement the EORTC Core instruments for assessment of Health Related Quality of Life in patients with Cancer Cachexia.

Awards and Honours

  • 1976: A three year scholarship from Temple University.
  • 2000: European Association of Oral Medicine, Prize for best oral presentation, Sweden.

Memberships

  • Athens Dental Association
  • Hellenic Society of Medical Mycology
  • Hellenic Society of Oral Oncology
  • Multinational Mediterranean Oncology Forum
  • Multinational Association of Supportive Care in Cancer
  • European organization for the Research & Treatment of Cancer/Quality of Life Group

Research Theses - Books

Books:

  • Oral lesions in oncology patients. Nicolatou-Galitis O. Bonissel publications. Athens 2001. Color Atlas.
  • Oral lesions in HIV/AIDS. Nicolatou-Galitis O. Athens 2006.

Chapters in book:

  • European Association of Oral Medicine – EAOM: Oral Medicine Handbook. EAOM 2004, on line, www.eastman.ucl.ac.uk/~eaom
  • Mucositis. Nicolatou-Galitis Ο, Spijkervet FKL., 2. Candidosis. Aguirre JM, Nicolatou-Galitis O.
  • EAOM Diagnostic and therapeutic protocols: Diagnosis and management of transplantation – related oral lesions. Protocol for diagnosis and management of transplantation – related oral lesions.Coordinator: Nicolatou-Galitis O.

 Selected publications in scientific journals

  1. Nicolatou-Galitis O, Sachanas S, Drogari-Apiranthitou M, Moschogiannis  M, Galiti D, Yiakoumis X, Rontogianni D, Yiotakis I, Petrikkos G, Pangalis G. Mucormycosis presenting with dental pain and palatal ulcer in a patient with chronic myelomonocytic Leukemia. Report of case and literature review. J Medical Microbiology Case Reports, 2015, in print.
  2. Lalla RV, Bowen J, Barasch A, Elting L, Epstein J, Keefe DM, McGuire DB, Migliorati C, Nicolatou-Galitis O, Peterson DE, Raber-Durlacher JE, Sonis ST, Elad S. MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy.Cancer 2014;120:1453-1461.
  3. Efficase F, Baccarani M, Saussele S, Abel G, Caocci G, Guilhot F, Cocks K, Naeem A, Sprangers M, Oerlemans S, Chie W, Castagnetti F, Bombaci F, Sharf G, Cardoni  A, Noens  L, Pallua S, Salvucci M, Nicolatou-Galitis O, Rosti G, Mandelli F. International development of an EORTC questionnaire for assessing health- related quality of life in chronic myeloid leukemia patients: the EORTC QLQ-CML24. Qual Life Res 2014;23:825-836.
  4. Nicolatou-Galitis O, Razis E, Galiti D, Vardas E, Tzerbos F, Labropoulos S. Osteonecrosis of the Jaw in a patient with chronic myelogenous leukemia receiving imatinib. A case report with clinical implications. Forum of Clinical Oncology 2013; 4:29-33.
  5. Nicolatou-Galitis O, Sarri T, Bowen J, Di Palma M, Kouloulias VE <Niscola P, Riesenbeck D, Stokman M, Tissing W, Yeoh E, Elad S, Lalla RV. Systematic review of anti-inflammatory agents for the management of oral mucositis in cancer patients. For the Mucositis Study Group of the Multinational Association of Supportive Care in Cancer / International Society of Oral Oncology. Support Care Cancer 2013;21:3179-3189.
  6. Nicolatou-Galitis O, Nikolaidi A, Athanassiadis I, Papadopoulou E, Sonis S.  Oral ulcers in patients with advanced breast cancer receiving everolimus: Clinical presentation and management. OSOMOP 2013;116:e110-e116.
  7. Singer S, Arraras JI, Chie WC, Fisher SE, Galalae R, Hammerlid E,  Nicolatou-Galitis O, Schmaltz C, Verdonck-de Leeuw I, Gamper E, Keszte J, Hofmeister D.  Performance of the EORTC questionnaire for the assessment of quality of life in head and neck cancer patients EORTC QLQ-H&N35: A methodological review. Qual Life Research 2013;22:1927-1941.
  8. Nicolatou-Galitis O, Sarri T, Bowen J, Di Palma M, Kouloulias VE, Niscola P, Riesenbeck D, Stokman M, Tissing W, Yeoh E, Elad S, Lalla RV. Systematic review of amifostine for the management of oral mucositis in cancer patients. For the Mucositis Study Group of the Multinational Association of Supportive Care in Cancer /International Society of Oral Oncology. Support Care Cancer 2013;21:357-364.
  9. Singer S, Arraras JI, Bauman I, Boehm A, Chie WC, Galalae R, Langendijk JA, Guntinas –Lichius  O, Hammerlid E, Pinto M, Nicolatou-Galitis O, Schmalz C, Sen M, Sherman AC, Spiegel K, Verdonck-de Leew  I, Yarom N, Zotti P, Hofmeister D. Quality of life in patients with head and neck cancer receiving targeted or multimodal therapy-Update of the EORTC QLQ-H&N35, Phase I. Head &Neck 2013;35:1331-1338.
  10. Nicolatou-Galitis O, Bafaloukos D, Manolakis G, Panayotidis P, Vardas E, Galiti D, Linardou E. Oral ulcers in cancer patients who  receive mTOR inhibitors: an emerging oral toxicity. Mediterranean Oncology Journal – MOJ 2012;2:45-51.

 Areas of scientific interest

  • Burden of Oral Mucositis in Oncology
  • Osteonecrosis of the jaws in oncology patients 
  • Oral Complications in standard Cancer Therapies
  • Oral complications in cancer targeted therapies
  • Oral Care in Cancer
  • Oral care in HSCT recipient
  • Quality of Life in Cancer

More content written by the author

Scopus

PubMed

Google Scholar